Salta al contenuto principale
Passa alla visualizzazione normale.

ANTONIO RUSSO

Fibronectin (FN), epidermal growth factor-receptor (EGF-R) and heparin-binding epidermal growth factor-like (HB-EGF) urinary expressions and topical toxicity of adjuvant intravesical therapy for non muscle invasive bladder cancer (NMI-BC)

  • Autori: Serretta, V; Alonge, V; Carità, G; Scalici Gesolfo, C; Caruso, S; Fiorentino, E; Russo, A; Torretta, F;
  • Anno di pubblicazione: 2014
  • Tipologia: eedings
  • Parole Chiave: bladder cancer, BCG, fibronectin, markers
  • OA Link: http://hdl.handle.net/10447/94777

Abstract

NMI bladder cancer, EGF-R, intravesical therapy. fibronectin